Market revenue in 2021 | USD 15.1 million |
Market revenue in 2030 | USD 117.0 million |
Growth rate | 25.6% (CAGR from 2021 to 2030) |
Largest segment | Serum biomarkers |
Fastest growing segment | Hepatic Fibrosis Biomarkers |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Serum Biomarkers, Hepatic Fibrosis Biomarkers, Apoptosis Biomarkers, Oxidative Stress Biomarkers |
Key market players worldwide | Genfit SA, Siemens AG, Quest Diagnostics Inc, AstraZeneca PLC, Meridian Bioscience, Labcorp Holdings Inc, Pfizer Inc, Bristol-Myers Squibb Co |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-alcoholic steatohepatitis biomarkers market will help companies and investors design strategic landscapes.
Serum biomarkers was the largest segment with a revenue share of 33.11% in 2021. Horizon Databook has segmented the South Korea non-alcoholic steatohepatitis biomarkers market based on serum biomarkers, hepatic fibrosis biomarkers, apoptosis biomarkers, oxidative stress biomarkers covering the revenue growth of each sub-segment from 2018 to 2030.
As per the Korean Biomedical Review, the South Korea nonalcoholic steatohepatitis biomarkers market is still at a nascent stage, and the industry needs support from the government to develop further to meet the rising demand for personalized medicine in the country.
As per Biological Research Information Centre (BRIC), majority of the laboratories and businesses are highly dependent on imported products and equipment from foreign companies to provide services in the country.
Domestic players are highly focused on genomic biomarkers while the industry is moving toward in vitro diagnostics. Similarly, companion diagnostics also have great growth potential. JW Bioscience, Aptamer Sciences, Genomictree, and WellMarker Bio are actively involved in development of predictive biomarkers in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea non-alcoholic steatohepatitis biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into South Korea non-alcoholic steatohepatitis biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account